Doctor Monica Mariana Baluta
University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)
Patients with prosthetic valve endocarditis admitted in non-reference centers may substantially benefit from infectious diseases specialist wisdom in antibiotic regimen selection
Event: Heart Failure 2019
Topic: Treatment
Session: Valvular Heart Disease
Type 2 diabetes is a strong predictor of mortality in patients with prosthetic valve endocarditis with or without heart failure
Event: Heart Failure 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Valvular Heart Disease
Anemia is an independent risk factor of adverse outcome in patients with prosthetic valve endocarditis and heart failure
Event: Heart Failure 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Valvular Heart Disease – Epidemiology, Prognosis, Outcome
Anticoagulant strategy for prosthetic valve in patients with endocarditis does not influence anemia, preexistent heart failure and mortality
Event: Heart Failure 2018
Topic: Treatment
Session: Valvular Heart Disease – Treatment
Short-term mortality is not influenced by aminoglycozide decrease in renal function during treatment of prosthetic valve endocarditis
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Valvular heart disease
Session: Valvular heart disease (diagnosis, management and interventional therapies)
Long-term results with conventional treatment approach for prosthetic valve endocarditis in patients with prior heart failure
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Valvular heart disease
Session: Valvular heart disease (diagnosis, management and interventional therapies)
Outcome predictors for short and long-term evolution in patients with prosthetic valve endocarditis and prior heart failure with initial conservative intention to treat
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: co-morbidities (other)
Session: Comorbodities
